Henry Schein (NASDAQ:HSIC) Price Target & New Coverage by Deutsche Bank
Analysts at Deutsche Bank has begun coverage on shares of Henry Schein (NASDAQ:HSIC) in analysts report made public on Wednesday morning. The financial company set Hold rating on the $13.56 billion market cap company.
In spite of the new coverage NASDAQ:HSIC is right now trading 0.00% lower at $171.25 as of 8:43 AM New York time. Henry Schein shares have [From2] 0% over the past 200 days, while the Standard & Poor’s 500 index has added 13.17% during the same time period.
According to data compiled by Thomson Reuters, Henry Schein (NASDAQ:HSIC)’s stock is covered by 10 equity analysts across the Street, with 0 analysts giving it a Sell rating, 6 a Buy rating, while 8 consider it a Hold. The 12-month consensus target price for the stock is $171.8, which reflects an upside potential of 0.32% over the current price.
Lombard Odier Asset Management (Switzerland) Sa had the largest stake with ownership of 100,000 shares as of q2 2015 for 3.89% of the US long stock exposure. North Point Portfolio Managers Corp Oh is another bullish investment manager who is owning 111,239 shares of Henry Schein or 3.45% of their US long stock exposure. Further, Alecta Pensionsforsakring Omsesidigt have 3.29% of their US long stock exposure invested in the company for 2.10M shares. The Colorado-based fund Gavekal Capital Llc disclosed it had purchased so far a stake worth about 2.96% of the investment manager’s stock portfolio in Henry Schein. The Delaware-based fund Green Valley Investors Llc is also positive about the stock, possessing 54,513 shares or 2.79% of their US long stock exposure.
Henry Schein (NASDAQ:HSIC) Profile
Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Henry Schein (NASDAQ:HSIC) closed at $171.25 yesterday. A total of shares of the company’s stock traded hands. This is down from average of 526,043 shares. Henry Schein has a 52 week low of $146.23 and a 52 week high of $183. The company has a market cap of $13.56 billion and a P/E ratio of 27.64.
Get the latest Henry Schein (NASDAQ:HSIC) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.
The post Analysts at Deutsche Bank Initiated Coverage of Henry Schein (NASDAQ:HSIC) with a Hold Rating. The Target Price is Set to $174.0 appeared first on Octafinance.